Literature DB >> 11597528

Worldwide experience with alfuzosin and tamsulosin.

M C Michel1, M T Flannery, P Narayan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11597528     DOI： 10.1016/s0090-4295(01)01335-8

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  9 in total

Review 1.  Advances in the design and synthesis of prazosin derivatives over the last ten years.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Expert Opin Ther Targets       Date:  2011-12-13       Impact factor: 6.902

2.  Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

3.  AUA Guidelines and Their Impact on the Management of BPH: An Update.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2004

Review 4.  Tamsulosin: an update of its role in the management of lower urinary tract symptoms.

Authors:  Katherine A Lyseng-Williamson; Blair Jarvis; Antona J Wagstaff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.

Authors:  Zuhair K Al-Hussaini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 6.  Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.

Authors:  Christopher J Dunn; Anna Matheson; Diana M Faulds
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.

Authors:  Petros Sountoulides; Marleen M van Dijk; Hessel Wijkstra; Jean J M C H de la Rosette; Martin Christian Michel
Journal:  World J Urol       Date:  2009-10-09       Impact factor: 4.226

Review 8.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 9.  Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia?

Authors:  Mohamed A Ghafar; Peter J Puchner; Aristotelis G Anastasiadis; Mark A Cabelin; Ralph Buttyan
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.